Raymond C. Stevens's most recent trade in Danaher Corp. was a trade of 168 Phantom shares done . Disclosure was reported to the exchange on July 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 168 | 6,727 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 1,478 | 1,478 | - | - | Director stock option (right to buy) | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 577 | 12,361 (0%) | 0% | 0 | Common Stock | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 175 | 6,559 | - | - | Phantom shares | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 826,890 | 826,890 | - | - | Employee Stock Option (right to buy) | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 340,332 | 1,133,678 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 89,697 | 1,210,880 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 01 Mar 2025 | 16,050 | 1,194,830 | - | 6.8 | 109,727 | Ordinary Shares |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.92 per share. | 01 Mar 2025 | 12,495 | 1,121,183 | - | 7.9 | 98,918 | Ordinary Shares |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 1,000 | 1,000 | - | - | American Depositary Shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 147 | 6,383 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 134 | 6,236 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 119 | 6,102 | - | - | Phantom shares | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share. | 12 Jun 2024 | 99,999 | 743,345 | - | 0.4 | 39,000 | Ordinary Shares |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 99,999 | 1 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.48 per share. | 12 Jun 2024 | 50,001 | 793,346 | - | 0.5 | 24,000 | Ordinary Shares |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 50,001 | 488,766 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | 10 Jun 2024 | 555,000 | 643,346 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Jun 2024 | 185,000 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | 10 Jun 2024 | 185,000 | 185,000 | - | - | American Depositary Shares | ||
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 1,081 | 1,081 | - | - | Director stock option (right to buy) | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 390 | 11,207 (0%) | 0% | 0 | Common Stock | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 133 | 5,982 | - | - | Phantom shares | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 335,481 | 335,481 | - | - | Stock Option (right to buy) | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 335,481 | 335,481 | - | - | Stock Option (right to buy) | |
| Structure Therapeutics Inc... | Raymond C. Stevens | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 134,682 | 1,198,346 | - | 0 | Ordinary Shares | |
| Danaher | C. Stevens Raymond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 140 | 5,848 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2023 | 174 | 5,708 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2023 | 125 | 4,916 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 1,194 | 1,194 | - | - | Director stock option (right to buy) | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 430 | 9,083 (0%) | 0% | 0 | Common Stock | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 137 | 4,791 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 121 | 4,653 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Sale of securities on an exchange or to another person at price $ 264.33 per share. | 25 Jan 2023 | 3,540 | 8,394 (0%) | 0% | 264.3 | 935,729 | Common Stock |
| Danaher | Raymond C. Stevens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.28 per share. | 25 Jan 2023 | 3,540 | 11,934 (0%) | 0% | 83.3 | 294,811 | Common Stock |
| Danaher | Raymond C. Stevens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 3,540 | 0 | - | - | Director stock option (right to buy) | |
| Danaher | Raymond C. Stevens | Director | Sale of securities on an exchange or to another person at price $ 264.22 per share. | 25 Jan 2023 | 2,640 | 8,394 (0%) | 0% | 264.2 | 697,541 | Common Stock |
| Danaher | Raymond C. Stevens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.24 per share. | 25 Jan 2023 | 2,640 | 11,034 (0%) | 0% | 100.2 | 264,634 | Common Stock |
| Danaher | Raymond C. Stevens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 2,640 | 0 | - | - | Director stock option (right to buy) | |
| Danaher | Raymond C. Stevens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.05 per share. | 25 Jan 2023 | 2,230 | 10,624 (0%) | 0% | 131.1 | 292,242 | Common Stock |
| Danaher | Raymond C. Stevens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 2,230 | 0 | - | - | Director stock option (right to buy) | |
| Danaher | Raymond C. Stevens | Director | Sale of securities on an exchange or to another person at price $ 264.23 per share. | 25 Jan 2023 | 2,230 | 8,394 (0%) | 0% | 264.2 | 589,244 | Common Stock |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 128 | 1,532 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 110 | 4,403 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2022 | 929 | 929 | - | - | Director stock option (right to buy) | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2022 | 372 | 8,154 (0%) | 0% | 0 | Common Stock | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 128 | 4,292 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 114 | 4,164 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 102 | 3,942 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 107 | 3,947 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2021 | 1,216 | 1,216 | - | - | Director Stock Option (Right to Buy) | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2021 | 365 | 7,329 (0%) | 0% | 0 | Common Stock | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 126 | 3,839 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 134 | 3,713 | - | - | Phantom shares | |
| Danaher | Raymond C. Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2020 | 138 | 3,579 | - | - | Phantom shares |